Pfizer

Bulgaria, Poland, Lithuania and Hungary insist on renegotiating the conditions for the supply of Pfizer's vaccines against COVID-19, according to a joint statement of their health ministers, quoted by the BTA correspondent in Brussels.

According to the announcement, they submitted their position to the EU Council of Health Ministers, which is meeting on Tuesday in Brussels.

Bulgaria and several other EU countries will insist that the European Health Commission terminate the contract with "Pfizer-Biontech" for the supply of covid vaccines, said acting Minister of Health Asen Medjidiev at a briefing.

In a statement they published on their website, the company "Pfizer" stated that they did not conduct research on Gain-of-function research (GoF research or GoFR) - a medical research that genetically alters an organism in a way that may enhance the biological function and the potential of viruses.

For the period from 02.08.2022 to the beginning of January 2023, 657,762 doses of the Comirnaty vaccine and 271,910 doses of the Spikevax vaccine expired. This was reported by the Acting Health Minister Asen Medzhidiev in response to a parliamentary question.

Ms Small appeared in the place of Pfizer chief executive Albert Bourla, who had been called to testify but pulled out of the hearing earlier this month

Vaccines to fight cancer will be widely available before 2030, say husband and wife Prof. Ugur Şahin and Prof. Özlem Tureçi, creators of one of the most successful vaccines against COVID-19, writes in the New York Times.

Lessons learned from the pandemic will accelerate cancer treatments based on mRNA technology, they say.

Ο ΕΜΑ συστήνει την έγκριση χορήγησης του εμβολίου της Pfizer για τις BA.4 και BA.5 της Omicron

Ljubljana – Some 370,000 doses of the Pfizer and Moderna vaccines so far approved against two sub-lineages of the Omicron variant of coronavirus will be delivered to Slovenia this week, with more shots to arrive by the end of the month, the National Institute for Public Health (NIJZ) told the STA on Tuesday.

The European Commission has called on EU countries to plan vaccination campaigns against COVID-19 in the autumn as a precaution before new waves of infection are expected after temperatures drop.

Pfizer's COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, according to a large study published on Aug. 24.